文章名稱引用次數(shù)

• Organ/body-on-a-chip based on microfluidic technology for drug discovery61
• Organs-on-a-chip: Current applications and consideration points for in vitro ADME-Tox studies17
• Therapeutic drug monitoring of monoclonal antibodies: Applicability based on their pharmacokinetic properties14
• Comparison of protein expression between human livers and the hepatic cell lines HepG Hep3B, and Huh7 using SWATH and MRM-HR proteomics: Focusing on drug-metabolizing enzymes10
• Effect of OATP1B1 genotypes on plasma concentrations of endogenous OATP1B1 substrates and drugs, and their association in healthy volunteers10
• Chimeric mice with humanized liver: Application in drug metabolism and pharmacokinetics studies for drug discovery9
• Applications of MALDI mass spectrometry imaging for pharmacokinetic studies during drug development8
• Physiologically-based modeling of monoclonal antibody pharmacokinetics in drug discovery and development7
• Minimal contribution of P-gp on the low brain distribution of naldemedine, a peripherally acting mu-opioid receptor antagonist6
• Importance of cynomolgus monkeys in development of monoclonal antibody drugs6